Review of recent methodological developments in group-randomized trials: Part 1 - Design

American Journal of Public Health

Volumn 107, Issue 6, 2017, Pages 907-915

  Turner, Elizabeth L ^a   Li, Fan ^a   Gallis, John A ^a   Prague, Melanie ^b,c   Murray, David M ^d  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c INRIA   (France)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GROUP THERAPY; HUMAN; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; CLUSTER ANALYSIS; METHODOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; STATISTICAL MODEL;

CLUSTER ANALYSIS; HUMANS; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE;

EID: 85020539148     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2017.303706     Document Type: Review

References (144)

1. Murray DM. Design and Analysis of Group-Randomized Trials. New York, NY: Oxford University Press; 1998.
2. Hayes RJ, Moulton LH. Cluster Randomised Trials. Boca Raton, FL: CRC Press; 2009.
3. Donner A, Klar N. Design and Analysis of Cluster Randomization Trials in Health Research. London, England: Arnold; 2000.
4. Eldridge S, Kerry S. A Practical Guide to Cluster Randomised Trials in Health Services Research. Chichester, UK: Wiley; 2012.
5. Campbell MJ, Walters SJ. How to Design, Analyse and Report Cluster Randomised Trials in Medicine and Health Related Research. Chichester, UK: Wiley; 2014.
6. Murray DM, Varnell SP, Blitstein JL. Design and analysis of group-randomized trials: a review of recent methodological developments. Am J Public Health. 2004; 94(3):423-432.
7. Turner EL, Prague M, Gallis JA, Li F, Murray DM. Review of recent methodological developments in group-randomized trials: part 2 - analysis. Am J Public Health. 2017;In press.
8. Campbell MK, Fayers PM, Grimshaw JM. Determinants of the intracluster correlation coefficient in cluster randomized trials: the case of implementation research. Clin Trials. 2005;2(2):99-107.
9. Eldridge SM, Ukoumunne OC, Carlin JB. The intra-cluster correlation coefficient in cluster randomized trials: a review of definitions. Int Stat Rev. 2009; 77(3):378-394.
10. Fiero MH, Huang S, Oren E, Bell ML. Statistical analysis and handling of missing data in cluster randomized trials: a systematic review. Trials. 2016;17:72.
11. Rutterford C, Taljaard M, Dixon S, Copas A, Eldridge S. Reporting and methodological quality of sample size calculations in cluster randomized trials could be improved: a review. J Clin Epidemiol. 2015;68(6):716-723.
12. Ridout MS, Demétrio CG, Firth D. Estimating intraclass correlation for binary data. Biometrics. 1999;55(1):137-148.
13. Chakraborty H, Moore J, Hartwell TD. Intracluster correlation adjustments to maintain power in cluster trials for binary outcomes. Contemp Clin Trials. 2009;30(5):473-480.
14. Thomson A, Hayes R, Cousens S. Measures of between-cluster variability in cluster randomized trials with binary outcomes. Stat Med. 2009;28(12): 1739-1751.
15. Yelland LN, Salter AB, Ryan P. Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data. Am J Epidemiol. 2011;174(8):984-992.
16. Crespi CM, Wong WK, Wu S. A new dependence parameter approach to improve the design of cluster randomized trials with binary outcomes. Clin Trials. 2011;8(6):687-698.
17. Wu S, Crespi CM, Wong WK. Comparison of methods for estimating the intraclass correlation coefficient for binary responses in cancer prevention cluster randomized trials. Contemp Clin Trials. 2012;33(5):869-880.
18. Jahn-Eimermacher A, Ingel K, Schneider A. Sample size in cluster-randomized trials with time to event as the primary endpoint. Stat Med. 2013;32(5):739-751.
19. Oliveira IR, Molenberghs G, Demétrio CG, Dias CT, Giolo SR, Andrade MC. Quantifying intraclass correlations for count and time-to-event data. Biom J. 2016;58(4):852-867.
20. Ukoumunne OC, Davison AC, Gulliford MC, Chinn S. Non-parametric bootstrap confidence intervals for the intraclass correlation coefficient. Stat Med. 2003;22(24):3805-3821.
21. Zou G, Donner A. Confidence interval estimation of the intraclass correlation coefficient for binary outcome data. Biometrics. 2004;60(3):807-811.
22. Turner RM, Toby Prevost A, Thompson SG. Allowing for imprecision of the intracluster correlation coefficient in the design of cluster randomized trials. Stat Med. 2004;23(8):1195-1214.
23. Turner RM, Thompson SG, Spiegelhalter DJ. Prior distributions for the intracluster correlation coefficient, based on multiple previous estimates, and their application in cluster randomized trials. Clin Trials. 2005;2(2):108-118.
24. Turner RM, Omar RZ, Thompson SG. Constructing intervals for the intracluster correlation coefficient using Bayesian modelling, and application in cluster randomized trials. Stat Med. 2006; 25(9):1443-1456.
25. Braschel MC, Svec I, Darlington GA, Donner A. A comparison of confidence interval methods for the intraclass correlation coefficient in community-based cluster randomization trials with a binary outcome. Clin Trials. 2016;13(2): 180-187.
26. Shoukri MM, Donner A, El-Dali A. Covariate-adjusted confidence interval for the intraclass correlation coefficient. Contemp Clin Trials. 2013;36(1):244-253.
27. Moerbeek M, Teerenstra S. Power Analysis of Trials With Multilevel Data. Boca Raton, FL: CRC Press; 2016.
28. Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. BMJ. 2004; 328(7441):702-708.
29. Laktabai J, Lesser A, Platt A, et al. Innovative public-private partnership to target subsidized antimalarials: a study protocol for a cluster randomised controlled trial to evaluate a community intervention in Western Kenya. BMJ Open. 2017;7(3):e013972.
30. Turner EL, Sikander S, Bangash O, et al. The effectiveness of the peer delivered Thinking Healthy Plus (THPP+) Programme for maternal depression and child socio-emotional development in Pakistan: study protocol for a three-year cluster randomized controlled trial. Trials. 2016;17(1):442. [Erratum in: The effectiveness of the peer delivered Thinking Healthy Plus (THPP+) Programme for maternal depression and child socioemotional development in Pakistan: study protocol for A three-year cluster randomized controlled trial. Trials. 2017]
31. comMIT Research Group. Community Intervention Trial for Smoking Cessation (COMMIT): summary of design and intervention. J Natl Cancer Inst. 1991;83(22):1620-1628.
32. Murray DM, Pals SP, Blitstein JL, Alfano CM, Lehman J. Design and analysis of group-randomized trials in cancer: a review of current practices. J Natl Cancer Inst. 2008;100(7):483-491.
33. Donner A. Sample size requirements for stratified cluster randomization designs. Stat Med. 1992;11(6):743-750.
34. Guittet L, Ravaud P, Giraudeau B. Planning a cluster randomized trial with unequal cluster sizes: practical issues involving continuous outcomes. BMC Med Res Methodol. 2006;6:17.
35. Carter B. Cluster size variability and imbalance in cluster randomized controlled trials. Stat Med. 2010;29(29): 2984-2993.
36. Lake S, Kaumann E, Klar N, Betensky R. Sample size re-estimation in cluster randomization trials. Stat Med. 2002; 21(10):1337-1350.
37. Manatunga AK, Hudgens MG, Chen SD. Sample size estimation in cluster randomized studies with varying cluster size. Biom J. 2001;43(1):75-86.
38. Kerry SM, Bland JM. Unequal cluster sizes for trials in English and Welsh general practice: implications for sample size calculations. Stat Med. 2001;20(3): 377-390.
39. Eldridge SM, Ashby D, Kerry S. Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method. Int J Epidemiol. 2006;35(5):1292-1300.
40. van Breukelen GJ, Candel MJ, Berger MP. Relative efficiency of unequal versus equal cluster sizes in cluster randomized and multicentre trials. Stat Med. 2007; 26(13):2589-2603.
41. Candel MJ, Van Breukelen GJ. Sample size adjustments for varying cluster sizes in cluster randomized trials with binary outcomes analyzed with second-order PQL mixed logistic regression. Stat Med. 2010;29(14):1488-1501.
42. You Z, Williams OD, Aban I, Kabagambe EK, Tiwari HK, Cutter G. Relative efficiency and sample size for cluster randomized trials with variable cluster sizes. Clin Trials. 2011;8(1):27-36.
43. Candel MJ, Van Breukelen GJ. Repairing the efficiency loss due to varying cluster sizes in two-level twoarmed randomized trials with heterogeneous clustering. Stat Med. 2016;35(12): 2000-2015.
44. Johnson JL, Kreidler SM, Catellier DJ, Murray DM, Muller KE, Glueck DH. Recommendations for choosing an analysis method that controls type I error for unbalanced cluster sample designs with Gaussian outcomes. Stat Med. 2015; 34(27):3531-3545.
45. Wright N, Ivers N, Eldridge S, Taljaard M, Bremner S. A review of the use of covariates in cluster randomized trials uncovers marked discrepancies between guidance and practice. J Clin Epidemiol. 2015;68(6):603-609.
46. Ivers NM, Halperin IJ, Barnsley J, et al. Allocation techniques for balance at baseline in cluster randomized trials: a methodological review. Trials. 2012;13:120.
47. Donner A, Klar N. Pitfalls of and controversies in cluster randomized trials. Am J Public Health. 2004;94(3):416-422.
48. Donner A, Taljaard M, Klar N. The merits of breaking the matches: a cautionary tale. Stat Med. 2007;26(9): 2036-2051.
49. Imai K, King G, Nall C. The essential role of pair matching in cluster randomized experiments, with application to the Mexican universal health insurance evaluation. Stat Sci. 2009;24(1): 29-53.
50. Hill J, Scott M.comment: the essential role of pair matching. Stat Sci. 2009; 24(1):54-58.
51. Zhang K, Small DS.comment: the essential role of pair matching in cluster randomized experiments, with application to the Mexican Universal Health Insurance Evaluation. Stat Sci. 2009;24(1): 59-64.
52. Imai K, King G, Nall C. Rejoinder: matched pairs and the future of cluster randomized experiments. Stat Sci. 2009; 24(1):65-72.
53. Klar N, Donner A. The merits of matching in community intervention trials: a cautionary tale. Stat Med. 1997; 16(15):1753-1764.
54. Imbens GW. Experimental design for unit and cluster randomized trials. Paper presented at: Initiative for Impact Evaluation. Cuernavaca, Mexico; June 15-17, 2011.
55. Raab GM, Butcher I. Balance in cluster randomized trials. Stat Med. 2001; 20(3):351-365.
56. Carter BR, Hood K. Balance algorithm for cluster randomized trials. BMC Med Res Methodol. 2008;8:65.
57. de Hoop E, Teerenstra S, van Gaal BG, Moerbeek M, Borm GF. The "best balance" allocation led to optimal balance in cluster-controlled trials. J Clin Epidemiol. 2012;65(2):132-137.
58. Li F, Lokhnygina Y, Murray DM, Heagerty PJ, DeLong ER. An evaluation of constrained randomization for the design and analysis of grouprandomized trials. Stat Med. 2016;35(10): 1565-1579.
59. Moulton LH. Covariate-based constrained randomization of grouprandomized trials. Clin Trials. 2004;1(3): 297-305.
60. Snedecor GW, Cochran WG. Statistical Methods. 8th ed. Ames: Iowa State University Press; 1989.
61. Murray DM, Hannan PJ, Baker WL.A Monte Carlo study of alternative responses to intraclass correlation in community trials. Is it ever possible to avoid Cornfield's penalties? Eval Rev. 1996;20(3): 313-337.
62. Donner A, Birkett N, Buck C. Randomization by cluster sample size requirements and analysis. Am J Epidemiol. 1981;114(6):906-914.
63. Cornfield J. Randomization by group: a formal analysis. Am J Epidemiol. 1978; 108(2):100-102.
64. Teerenstra S, Eldridge S, Graff M, Hoop E, Borm GF. A simple sample size formula for analysis of covariance in cluster randomized trials. Stat Med. 2012;31(20): 2169-2178.
65. Heo M, Kim Y, Xue X, Kim MY. Sample size requirement to detect an intervention effect at the end of follow-up in a longitudinal cluster randomized trial. Stat Med. 2010;29(3):382-390.
66. Murray DM, Blitstein JL, Hannan PJ, Baker WL, Lytle LA. Sizing a trial to alter the trajectory of health behaviours: methods, parameter estimates, and their application. Stat Med. 2007;26(11): 2297-2316.
67. Teerenstra S, Lu B, Preisser JS, van Achterberg T, Borm GF. Sample size considerations for GEE analyses of three-level cluster randomized trials. Biometrics. 2010;66(4):1230-1237.
68. Heo M, Leon AC. Statistical power and sample size requirements for three level hierarchical cluster randomized trials. Biometrics. 2008;64(4):1256-1262.
69. Teerenstra S, Moerbeek M, van Achterberg T, Pelzer BJ, Borm GF. Sample size calculations for 3-level cluster randomized trials. Clin Trials. 2008;5(5): 486-495.
70. Heo M. Impact of subject attrition on sample size determinations for longitudinal cluster randomized clinical trials. J Biopharm Stat. 2014;24(3):507-522.
71. Heo M, Leon AC. Sample size requirements to detect an intervention by time interaction in longitudinal cluster randomized clinical trials. Stat Med. 2009; 28(6):1017-1027.
72. Heo M, Litwin AH, Blackstock O, Kim N, Arnsten JH. Sample size determinations for group-based randomized clinical trials with different levels of data hierarchy between experimental and control arms. Stat Methods Med Res. 2014; 26(1):399-413.
73. HeoM, Xue X, Kim MY. Sample size requirements to detect an intervention by time interaction in longitudinal cluster randomized clinical trials with random slopes.comput Stat Data Anal. 2013;60: 169-178.
74. Konstantopoulos S. Incorporating cost in power analysis for three-level cluster randomized designs. Eval Rev. 2009;33(4): 335-357.
75. Hemming K, Girling AJ, Sitch AJ, Marsh J, Lilford RJ. Sample size calculations for cluster randomised controlled trials with a fixed number of clusters. BMC Med Res Methodol. 2011;11:102.
76. Ahn C, Hu F, Skinner CS, Ahn D. Effect of imbalance and intracluster correlation coefficient in cluster randomization trials with binary outcomes when the available number of clusters is fixed in advance. Contemp Clin Trials. 2009;30(4): 317-320.
77. Candel MJ, Van Breukelen GJ. Varying cluster sizes in trials with clusters in one treatment arm: sample size adjustments when testing treatment effects with linear mixed models. Stat Med. 2009; 28(18):2307-2324.
78. Durán Pacheco G, Hattendorf J, Colford JM Jr, Mäusezahl D, Smith T. Performance of analytical methods for overdispersed counts in cluster randomized trials: sample size, degree of clustering and imbalance. Stat Med. 2009;28(24): 2989-3011.
79. Rutterford C, Copas A, Eldridge S. Methods for sample size determination in cluster randomized trials. Int J Epidemiol. 2015;44(3):1051-1067.
80. Gao F, Earnest A, Matchar DB, Campbell MJ, Machin D. Sample size calculations for the design of cluster randomized trials: a summary of methodology. Contemp Clin Trials. 2015;42:41-50.
81. Spiegelman D. Evaluating public health interventions: 2. Stepping up to routine public health evaluation with the stepped wedge design. Am J Public Health. 2016;106(3):453-457.
82. Brown CA, Lilford RJ. The stepped wedge trial design: a systematic review. BMC Med Res Methodol. 2006;6:54.
83. Mdege ND, Man MS, Taylor Nee Brown CA, Torgerson DJ. Systematic review of stepped wedge cluster randomized trials shows that design is particularly used to evaluate interventions during routine implementation. J Clin Epidemiol. 2011;64(9):936-948.
84. Beard E, Lewis JJ, Copas A, et al. Stepped wedge randomised controlled trials: systematic review of studies published between 2010 and 2014. Trials. 2015;16:353.
85. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007; 28(2):182-191.
86. Hargreaves JR, Copas AJ, Beard E, et al. Five questions to consider before conducting a stepped wedge trial. Trials. 2015;16:350.
87. Moulton LH, Golub JE, Durovni B, et al. Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. Clin Trials. 2007;4(2):190-199.
88. Prost A, Binik A, Abubakar I, et al. Logistic, ethical, and political dimensions of stepped wedge trials: critical review and case studies. Trials. 2015;16:351.
89. Shah More N, Das S, Bapat U, et al.community resource centres to improve the health of women and children in Mumbai slums: study protocol for a cluster randomized controlled trial. Trials. 2013; 14:132.
90. Hemming K, Lilford R, Girling AJ. Stepped-wedge cluster randomised controlled trials: a generic framework including parallel and multiple-level designs. Stat Med. 2015;34(2):181-196.
91. Kotz D, Spigt M, Arts IC, Crutzen R, Viechtbauer W. Use of the stepped wedge design cannot be recommended: a critical appraisal and comparison with the classic cluster randomized controlled trial design. J Clin Epidemiol. 2012;65(12): 1249-1252.
92. Kotz D, Spigt M, Arts IC, Crutzen R, Viechtbauer W. Researchers should convince policy makers to perform a classic cluster randomized controlled trial instead of a stepped wedge design when an intervention is rolled out. J Clin Epidemiol. 2012;65(12):1255-1256.
93. Murray DM, Pennell M, Rhoda D, Hade EM, Paskett ED. Designing studies that would address the multilayered nature of health care. J Natl Cancer Inst Monogr. 2010;2010(40):90-96.
94. Hayes RJ, Alexander ND, Bennett S, Cousens SN. Design and analysis issues in cluster-randomized trials of interventions against infectious diseases. Stat Methods Med Res. 2000;9(2):95-116.
95. Copas AJ, Lewis JJ, Thompson JA, Davey C, Baio G, Hargreaves JR. Designing a stepped wedge trial: three main designs, carry-over effects and randomisation approaches. Trials. 2015;16:352.
96. Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ. The steppedwedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ. 2015;350: h391.
97. Baio G, Copas A, Ambler G, Hargreaves J, Beard E, Omar RZ. Sample size calculation for a stepped wedge trial. Trials. 2015;16:354.
98. Handley MA, Schillinger D, Shiboski S. Quasi-experimental designs in practice-based research settings: design and implementation considerations. J Am Board Fam Med. 2011;24(5):589-596.
99. Liao X, Zhou X, Spiegelman D. A note on "Design and analysis of stepped wedge cluster randomized trials." Contemp Clin Trials. 2015;45(pt B):338-339. [Comment on: Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007].
100. Hemming K, Taljaard M. Sample size calculations for stepped wedge and cluster randomised trials: a unified approach. J Clin Epidemiol. 2016;69:137-146.
101. Hemming K, Girling A. A menudriven facility for power and detectabledifference calculations in stepped-wedge cluster-randomized trials. Stata J. 2014; 14(2):363-380.
102. Hughes J. Calculation of power for stepped wedge design. Available at: http://tinyurl.com/hwp5dgr. Accessed January 12, 2017.
103. Hughes J. Calculation of power for stepped wedge design (means). Available at: http://tinyurl.com/jvcr5bu. Accessed January 12, 2017.
104. Baio G. SWSamp: simulation-based sample size calculations for a stepped wedge trial (and more). 2016. Available at: https://sites.google.com/a/statistica.it/gianluca/swsamp. Accessed January 25, 2017.
105. Lawrie J, Carlin JB, Forbes AB. Optimal stepped wedge designs. Stat Probab Lett. 2015;99:210-214.
106. Girling AJ, Hemming K. Statistical efficiency and optimal design for stepped cluster studies under linear mixed effects models. Stat Med. 2016;35(13): 2149-2166.
107. Hudgens MG, Halloran ME. Toward causal inference with interference. J Am Stat Assoc. 2008;103(482):832-842.
108. Wang R, Goyal R, Lei Q, Essex M, De Gruttola V. Sample size considerations in the design of cluster randomized trials of combination HIV prevention. Clin Trials. 2014;11(3):309-318.
109. Latkin C, Donnell D, Liu TY, Davey-Rothwell M, Celentano D, Metzger D. The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users. Addiction. 2013;108(5):934-943.
110. Staples PC, Ogburn EL, Onnela JP. Incorporating contact network structure in cluster randomized trials. Sci Rep. 2015; 5:17581.
111. Harling G, Wang R, Onnela JP, De Gruttola V. Leveraging contact network structure in the design of cluster randomized trials. Clin Trials. 2017;14(1): 37-47.
112. Keeling MJ, Woolhouse ME, May RM, Davies G, Grenfell B. Modelling vaccination strategies against foot-andmouth disease. Nature. 2003;421(6919): 136-142.
113. Kretzschmar M, Van den Hof S, Wallinga J, Van Wijngaarden J. Ring vaccination and smallpox control. Emerg Infect Dis. 2004;10(5):832-841.
114. Enserink M. The Ebola epidemic. High hopes for Guinean vaccine trial. Science. 2015;347(6219):219-220.
115. Ebola Ça Suffit Ring Vaccination Trial Consortium. The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola. BMJ. 2015;351: h3740.
116. Farrin A, Russell I, Torgerson D, Underwood M; UK Beam Trial Team. Differential recruitment in a cluster randomized trial in primary care: the experience of the UK back pain, exercise, active management and manipulation (UK BEAM) feasibility study. Clin Trials. 2005;2(2):119-124.
117. Borm GF, Melis RJ, Teerenstra S, Peer PG. Pseudo cluster randomization: a treatment allocation method to minimize contamination and selection bias. Stat Med. 2005;24(23):3535-3547.
118. Melis RJ, van Eijken MI, Borm GF, et al. The design of the Dutch EASYcare study: a randomised controlled trial on the effectiveness of a problem-based community intervention model for frail elderly people. BMC Health Serv Res. 2005;5:65.
119. Pence BW, Gaynes BN, Thielman NM, et al. Balancing contamination and referral bias in a randomized clinical trial: an application of pseudocluster randomization. Am J Epidemiol. 2015; 182(12):1039-1046.
120. Melis RJ, Teerenstra S, Rikkert MG, Borm GF. Pseudo cluster randomization performed well when used in practice. J Clin Epidemiol. 2008;61(11):1169-1175.
121. Pence BW, Gaynes BN, Adams JL, et al. The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial. AIDS. 2015;29(15):1975-1986.
122. Teerenstra S, Melis RJ, Peer PG, Borm GF. Pseudo cluster randomization dealt with selection bias and contamination in clinical trials. JClin Epidemiol. 2006; 59(4):381-386.
123. Pals SL, Murray DM, Alfano CM, Shadish WR, Hannan PJ, Baker WL. Individually randomized group treatment trials: a critical appraisal of frequently used design and analytic approaches. Am J Public Health. 2008;98(8):1418-1424.
124. Baldwin SA, Bauer DJ, Stice E, Rohde P. Evaluating models for partially clustered designs. Psychol Methods. 2011; 16(2):149-165.
125. Carlbring P, Bohman S, Brunt S, et al. Remote treatment of panic disorder: a randomized trial of Internet-based cognitive behavior therapy supplemented with telephone calls. AmJ Psychiatry. 2006; 163(12):2119-2125.
126. Jeffery RW, Linde JA, Finch EA, Rothman AJ, King CM. A satisfaction enhancement intervention for long-term weight loss. Obesity (Silver Spring). 2006; 14(5):863-869.
127. Jackson KM, Aiken LS. Evaluation of a multicomponent appearance-based sun-protective intervention for young women: uncovering the mechanisms of program efficacy. Health Psychol. 2006; 25(1):34-46.
128. Roberts C, Roberts SA. Design and analysis of clinical trials with clustering effects due to treatment. Clin Trials. 2005; 2(2):152-162.
129. Kahan BC, Morris TP. Assessing potential sources of clustering in individually randomised trials. BMC Med Res Methodol. 2013;13:58.
130. Pals SL, Wiegand RE, Murray DM. Ignoring the group in group-level HIV/AIDS intervention trials: a review of reported design and analytic methods. AIDS. 2011;25(7):989-996.
131. Lee KJ, Thompson SG. Clustering by health professional in individually randomised trials. BMJ. 2005;330(7483): 142-144.
132. Biau DJ, Porcher R, Boutron I. The account for provider and center effects in multicenter interventional and surgical randomized controlled trials is in need of improvement: a review. J Clin Epidemiol. 2008;61(5):435-439.
133. Oltean H, Gagnier JJ. Use of clustering analysis in randomized controlled trials in orthopaedic surgery. BMC Med Res Methodol. 2015;15:17.
134. Moerbeek M, Wong WK. Sample size formulae for trials comparing group and individual treatments in a multilevel model. Stat Med. 2008;27(15):2850-2864.
135. Roberts C, Walwyn R. Design and analysis of non-pharmacological treatment trials with multiple therapists per patient. Stat Med. 2013;32(1):81-98.
136. Andridge RR, Shoben AB, Muller KE, Murray DM. Analytic methods for individually randomized group treatment trials and group-randomized trials when subjects belong to multiple groups. Stat Med. 2014;33(13):2178-2190.
137. Eldridge SM, Costelloe CE, Kahan BC, Lancaster GA, Kerry SM. How big should the pilot study for my cluster randomised trial be? Stat Methods Med Res. 2016;25(3):1039-1056.
138. Crespi CM. Improved designs for cluster randomized trials. Annu. Rev. Public Health. 2016;37:1-16.
139. Rietbergen C, Moerbeek M. The design of cluster randomized crossover trials. J Educ Behav Stat. 2011;36(4): 472-490.
140. Giraudeau B, Ravaud P, Donner A. Sample size calculation for cluster randomized cross-over trials. Stat Med. 2008; 27(27):5578-5585.
141. Arnup SJ, Forbes AB, Kahan BC, Morgan KE, McKenzie JE. The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality. Trials. 2016;17(1):575.
142. Mdege ND, Brabyn S, Hewitt C, Richardson R, Torgerson DJ. The 2 2 cluster randomized controlled factorial trial design is mainly used for efficiency and to explore intervention interactions: a systematic review. J Clin Epid. 2014;67(10):1083-1092.
143. Pennell ML, Hade EM, Murray DM, Rhoda DA. Cutoff designs for community-based intervention studies. Stat Med. 2011;30(15):1865-1882.
144. Schochet PZ. Statistical power for regression discontinuity designs in education evaluations. J Educ Behav Stat. 2009; 34(2):238-266.